Details

Biologic drugs (Schedule D drugs) – Division 4 proposed regulatory amendments: Notice to stakeholders - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 19, 2025 · edition #1
Timestamp: 2025-04-19T05:26:49.146Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/programs/consultation-proposed-agile-regulations-guidance-licensing-drugs-medical-devices/biologic-drugs-schedule-d-division-4-proposed-regulatory-amendments-notice.html?wbdisable=true
Replay URL: https://replay.healtharchive.ca/job-1/20250419052649/https://www.canada.ca/en/health-canada/programs/consultation-proposed-agile-regulations-guidance-licensing-drugs-medical-devices/biologic-drugs-schedule-d-division-4-proposed-regulatory-amendments-notice.html?wbdisable=true#ha_snapshot=199661
ID: 199661
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots